Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Cureus ; 14(1): e21518, 2022 Jan.
Article in English | MEDLINE | ID: mdl-35223294

ABSTRACT

Deep brain stimulation (DBS) is a commonly used treatment for medically refractory movement disorders and epilepsy. Intraoperative testing of electrode impedances is routinely done during DBS surgery to identify electrical conduction defects in the system. We present two illustrative cases involving elevated intraoperative impedances. In the first case, the temporal evolution of impedance changes and a postoperative head CT were consistent with a small and slowly resolving air collection along the lead. In the second case, an abnormally high impedance reading was observed at a single electrode and then "transferred" to be observed at an adjacent electrode upon adjustments of the electrode position, likely due to small air collection at a fixed position in the brain tissue. In both cases, careful troubleshooting allowed identification of the issue and avoidance of unnecessary surgical revisions. A thorough understanding of the possible sources of, and troubleshooting for, abnormal impedance readings is needed for effective intraoperative DBS monitoring.

2.
BMC Cancer ; 13: 549, 2013 Nov 16.
Article in English | MEDLINE | ID: mdl-24237932

ABSTRACT

BACKGROUND: Resistance to platinum-based chemotherapy remains a major impediment in the treatment of serous epithelial ovarian cancer. The objective of this study was to use gene expression profiling to delineate major deregulated pathways and biomarkers associated with the development of intrinsic chemotherapy resistance upon exposure to standard first-line therapy for ovarian cancer. METHODS: The study cohort comprised 28 patients divided into two groups based on their varying sensitivity to first-line chemotherapy using progression free survival (PFS) as a surrogate of response. All 28 patients had advanced stage, high-grade serous ovarian cancer, and were treated with standard platinum-based chemotherapy. Twelve patient tumours demonstrating relative resistance to platinum chemotherapy corresponding to shorter PFS (< eight months) were compared to sixteen tumours from platinum-sensitive patients (PFS > eighteen months). Whole transcriptome profiling was performed using an Affymetrix high-resolution microarray platform to permit global comparisons of gene expression profiles between tumours from the resistant group and the sensitive group. RESULTS: Microarray data analysis revealed a set of 204 discriminating genes possessing expression levels which could influence differential chemotherapy response between the two groups. Robust statistical testing was then performed which eliminated a dependence on the normalization algorithm employed, producing a restricted list of differentially regulated genes, and which found IGF1 to be the most strongly differentially expressed gene. Pathway analysis, based on the list of 204 genes, revealed enrichment in genes primarily involved in the IGF1/PI3K/NF κB/ERK gene signalling networks. CONCLUSIONS: This study has identified pathway specific prognostic biomarkers possibly underlying a differential chemotherapy response in patients undergoing standard platinum-based treatment of serous epithelial ovarian cancer. In addition, our results provide a pathway context for further experimental validations, and the findings are a significant step towards future therapeutic interventions.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Drug Resistance, Neoplasm/genetics , Insulin-Like Growth Factor I/genetics , NF-kappa B/genetics , Neoplasms, Glandular and Epithelial/drug therapy , Neoplasms, Glandular and Epithelial/genetics , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/genetics , Phosphatidylinositol 3-Kinases/genetics , Aged , Carcinoma, Ovarian Epithelial , Cluster Analysis , Female , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Gene Regulatory Networks , Humans , Insulin-Like Growth Factor I/metabolism , Middle Aged , NF-kappa B/metabolism , Neoplasm Grading , Neoplasms, Glandular and Epithelial/mortality , Neoplasms, Glandular and Epithelial/pathology , Ovarian Neoplasms/mortality , Ovarian Neoplasms/pathology , Phosphatidylinositol 3-Kinases/metabolism , Reproducibility of Results , Signal Transduction , Treatment Outcome
3.
Orphanet J Rare Dis ; 8: 33, 2013 Feb 21.
Article in English | MEDLINE | ID: mdl-23433318

ABSTRACT

BACKGROUND: The biology of small cell ovarian carcinoma of the hypercalcemic type (SCCOHT), which is a rare and aggressive form of ovarian cancer, is poorly understood. Tumourigenicity, in vitro growth characteristics, genetic and genomic anomalies, and sensitivity to standard and novel chemotherapeutic treatments were investigated in the unique SCCOHT cell line, BIN-67, to provide further insight in the biology of this rare type of ovarian cancer. METHOD: The tumourigenic potential of BIN-67 cells was determined and the tumours formed in a xenograft model was compared to human SCCOHT. DNA sequencing, spectral karyotyping and high density SNP array analysis was performed. The sensitivity of the BIN-67 cells to standard chemotherapeutic agents and to vesicular stomatitis virus (VSV) and the JX-594 vaccinia virus was tested. RESULTS: BIN-67 cells were capable of forming spheroids in hanging drop cultures. When xenografted into immunodeficient mice, BIN-67 cells developed into tumours that reflected the hypercalcemia and histology of human SCCOHT, notably intense expression of WT-1 and vimentin, and lack of expression of inhibin. Somatic mutations in TP53 and the most common activating mutations in KRAS and BRAF were not found in BIN-67 cells by DNA sequencing. Spectral karyotyping revealed a largely normal diploid karyotype (in greater than 95% of cells) with a visibly shorter chromosome 20 contig. High density SNP array analysis also revealed few genomic anomalies in BIN-67 cells, which included loss of heterozygosity of an estimated 16.7 Mb interval on chromosome 20. SNP array analyses of four SCCOHT samples also indicated a low frequency of genomic anomalies in the majority of cases. Although resistant to platinum chemotherapeutic drugs, BIN-67 cell viability in vitro was reduced by > 75% after infection with oncolytic viruses. CONCLUSIONS: These results show that SCCOHT differs from high-grade serous carcinomas by exhibiting few chromosomal anomalies and lacking TP53 mutations. Although BIN-67 cells are resistant to standard chemotherapeutic agents, their sensitivity to oncolytic viruses suggests that their therapeutic use in SCCOHT should be considered.


Subject(s)
Carcinoma, Small Cell/genetics , Genomic Instability , Ovarian Neoplasms/genetics , Animals , Antineoplastic Agents/therapeutic use , Carcinoma, Small Cell/drug therapy , Carcinoma, Small Cell/therapy , Chromosome Aberrations , Female , Gene Expression Profiling , Humans , Karyotyping , Mice , Mutation , Oncolytic Virotherapy , Ovarian Neoplasms/drug therapy , Ovarian Neoplasms/therapy , Polymorphism, Single Nucleotide , Xenograft Model Antitumor Assays
4.
J Interpers Violence ; 26(14): 2747-63, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21282125

ABSTRACT

Men who batter, because of particular personality traits and sense of entitlement, may select partners whom they perceive will be dependent on them, meet their emotional needs, or be "objects" of physical attractiveness. During treatment intake, 181 offenders responded to the question, "What attracted you to her (your partner)?" We explored whether men who mentioned their own needs or her physical traits would engage in more frequent and severe violence and would have specific forms of personality disorder dimensions or personality traits. Six categories of attraction, including "her physical traits" and "his needs," were derived from the men's responses. The results showed that men who focused on their partners' physical attractiveness were more likely to be violent after treatment. Men who cited their own needs for their attraction had higher scores on borderline personality, alcohol abuse, and psychotic thinking and lower scores on compulsive-conforming.


Subject(s)
Aggression/psychology , Coercion , Heterosexuality/psychology , Interpersonal Relations , Personality , Sexual Partners/psychology , Spouse Abuse/psychology , Adult , Beauty , Humans , Internal-External Control , Male , Middle Aged , Personal Satisfaction , Surveys and Questionnaires , Young Adult
5.
Endocrinology ; 151(3): 929-38, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20056833

ABSTRACT

Epithelial ovarian cancer is thought to be derived from the ovarian surface epithelium (OSE) but often goes undetected in the early stages, and as a result, the factors that contribute to its initiation and progression remain poorly understood. Epidemiological studies have suggested that the female steroid hormones are involved in ovarian carcinogenesis and that women who use hormone replacement therapy are at increased risk of developing the disease. A novel transgenic mouse model of ovarian cancer (tgCAG-LS-TAg) was developed to examine the role of the female reproductive steroid hormones [17beta-estradiol (E(2)) and progesterone (P(4))] on the initiation, progression, and pathology of ovarian cancer. The mouse model uses the Cre-LoxP system to induce expression of the simian virus 40 large and small T antigens (SV40 TAg). After targeted induction of the oncogene in the OSE, mice develop poorly differentiated ovarian tumors, tumor dissemination to tissues within the abdominal cavity, and a subset develops hemorrhagic ascites. Treatment with P(4) had no impact on the disease, but E(2) altered the pathophysiology, resulting in an earlier onset of tumors, decreased overall survival time, and a distinctive papillary histology. Normal ovaries collected from mice treated with E(2), but lacking expression of SV40 TAg, displayed an increase in the areas of columnar and hyperplastic OSE cells compared to placebo-treated controls. A better understanding of the mechanisms by which E(2) alters the morphology of normal OSE cells and reduces survival in this mouse model may translate into improved prevention and treatment options for women using hormone replacement therapy.


Subject(s)
Estradiol/adverse effects , Ovarian Neoplasms/chemically induced , Precancerous Conditions/chemically induced , Progesterone/adverse effects , Animals , Antigens, Polyomavirus Transforming/genetics , Female , Mice , Mice, Transgenic , Neoplasms, Experimental , Oncogenes , Ovarian Neoplasms/genetics , Phenotype
6.
N Engl J Med ; 360(26): 2719-29, 2009 Jun 25.
Article in English | MEDLINE | ID: mdl-19516027

ABSTRACT

BACKGROUND: Granulosa-cell tumors (GCTs) are the most common type of malignant ovarian sex cord-stromal tumor (SCST). The pathogenesis of these tumors is unknown. Moreover, their histopathological diagnosis can be challenging, and there is no curative treatment beyond surgery. METHODS: We analyzed four adult-type GCTs using whole-transcriptome paired-end RNA sequencing. We identified putative GCT-specific mutations that were present in at least three of these samples but were absent from the transcriptomes of 11 epithelial ovarian tumors, published human genomes, and databases of single-nucleotide polymorphisms. We confirmed these variants by direct sequencing of complementary DNA and genomic DNA. We then analyzed additional tumors and matched normal genomic DNA, using a combination of direct sequencing, analyses of restriction-fragment-length polymorphisms, and TaqMan assays. RESULTS: All four index GCTs had a missense point mutation, 402C-->G (C134W), in FOXL2, a gene encoding a transcription factor known to be critical for granulosa-cell development. The FOXL2 mutation was present in 86 of 89 additional adult-type GCTs (97%), in 3 of 14 thecomas (21%), and in 1 of 10 juvenile-type GCTs (10%). The mutation was absent in 49 SCSTs of other types and in 329 unrelated ovarian or breast tumors. CONCLUSIONS: Whole-transcriptome sequencing of four GCTs identified a single, recurrent somatic mutation (402C-->G) in FOXL2 that was present in almost all morphologically identified adult-type GCTs. Mutant FOXL2 is a potential driver in the pathogenesis of adult-type GCTs.


Subject(s)
Forkhead Transcription Factors/genetics , Granulosa Cell Tumor/genetics , Mutation, Missense , Ovarian Neoplasms/genetics , Base Sequence , Female , Forkhead Box Protein L2 , Gene Expression Profiling , Genetic Markers , Genotype , Granulosa Cell Tumor/diagnosis , Granulosa Cell Tumor/pathology , Humans , Immunohistochemistry , Ovarian Neoplasms/diagnosis , Ovarian Neoplasms/pathology , Point Mutation , Sequence Analysis, RNA , Taq Polymerase
7.
Mol Ther ; 10(6): 1032-42, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15564135

ABSTRACT

Improvement of ovarian cancer patient outcome requires well-characterized animal models in which to evaluate novel therapeutics. Xenograft models are frequently used, but with little discussion of disease histology. The objectives of this study were to inject 11 ovarian cancer cell lines intraperitoneally (ip), and a subset intrabursally (ib; orthotopic), into nude mice and to analyze the resulting pathologies. Eight of 11 lines injected ip formed tumors within 3 months at variable rates with the following histological subtype distribution: one endometrioid, one serous, one clear cell, and five undifferentiated. Only mice injected with A2780-cp cells presented with ovarian-specific metastases (11 of 88), and the survival time of these animals was significantly shorter, which may be attributed to the higher proliferation rate as determined by Ki67 positivity. Additional analysis of the influence of the ovarian microenvironment on cell characteristics was conducted with ib injection of two cell lines (OVCA 429 and ES-2). The site of injection did not affect the tumor histology, the effect on proliferation was cell-type dependent, and the tumor take rate (cell survival) was negatively affected for OVCA 429 cells. The animal models described herein represent histologically distinct models of both early and late stage ovarian cancer useful for evaluation of therapeutics.


Subject(s)
Disease Models, Animal , Neoplasm Metastasis/pathology , Ovarian Neoplasms/pathology , Peritoneum/pathology , Animals , Biomarkers, Tumor/blood , Cell Line, Tumor , Cell Proliferation , Female , Humans , Mice , Mice, Nude , Neoplasm Transplantation/pathology , Ovarian Neoplasms/diagnosis , Survival Rate , Transplantation, Heterologous/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...